Oxford Immunotec has appointed Todd Wauters as Vice President of Sales. Previously, Todd served as Vice President of Sales and Training at Integrated Genetics, LabCorp Specialty Testing Group (Genzyme Genetics was acquired by LabCorp. in 2010). Prior, Todd held increasingly responsible regional sales roles at Genzyme Genetics. Earlier in his career, he served in roles of increasing responsibility at UroCor, Inc., most recently as Director of Sales, and was also Managed Care Specialist and Sales Representative at TAP Pharmaceuticals and Government Sales Representative at Mitech Data Systems, Inc. 

Todd received a B.S. from George Mason University. 

About Oxford Immunotec Global PLC 

Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Its proprietary T-SPOT technology platform allows it to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body’s immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. Oxford Immunotec Global PLC is headquartered near Oxford, UK and in Marlborough, MA.